Second Sight Medical (NASDAQ:EYES)

Retinal prosthesis system that utilizes electrical stimulation to partially restore sight in patients blinded by outer retinal degeneration

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Second Sight Medical (NASDAQ:EYES) plus 5056 other startups.

Start Free 7 Day Trial Now

Learn More About Second Sight Medical (NASDAQ:EYES)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

Competing Startups

More

Our Clients